Loading...
A National Approach to Reimbursement Decision-Making on Drugs for Rare Diseases in Canada? Insights from Across the Ponds
INTRODUCTION: Regardless of the type of health system or payer, coverage decisions on drugs for rare diseases (DRDs) are challenging. While these drugs typically represent the only active treatment option for a progressive and/or life-threatening condition, evidence of clinical benefit is often limi...
Na minha lista:
| Udgivet i: | Healthc Policy |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Longwoods Publishing
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4748348/ https://ncbi.nlm.nih.gov/pubmed/26142357 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|